Mosapramine
Antipsychotic medication
From Wikipedia, the free encyclopedia
Mosapramine (Cremin) is an atypical antipsychotic used in Japan for the treatment of schizophrenia.[1][2] It is a potent dopamine antagonist with high affinity to the D2, D3, and D4 receptors,[3] and with moderate affinity for the 5-HT2 receptors.[4]
Trade namesCremin (クレミン, JP)
Routes of
administrationOral (tablets, oral solution)
administrationOral (tablets, oral solution)
| Clinical data | |
|---|---|
| Trade names | Cremin (クレミン, JP) |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral (tablets, oral solution) |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C28H35ClN4O |
| Molar mass | 479.07 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
See also
- Carpipramine
- Clocapramine
- Fluspirilene (typical antipsychotic)
- Imidazopyridine